These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 181422)

  • 1. [Prevention of the malignant form of trophoblastic disease after a hydatidiform mole: systematic or selective chemotherapy].
    Delvoye P; Robyn C
    J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):267-93. PubMed ID: 181422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy in placental tumors].
    Amiel JL; Droz JP
    J Gynecol Obstet Biol Reprod (Paris); 1977 Mar; 6(2):261-70. PubMed ID: 196002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
    Kanda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
    Lertkhachonsuk R; Limpongsanurak S
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL; Russell HT
    Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G; Pürstner P
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
    Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the results of hydatidiform mole managed by Niigata method].
    Hando T; Kodama S; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2722-30. PubMed ID: 4086902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
    Ngan HY; Wong LC
    Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asian approaches in the treatment of trophoblastic disease.
    Teoh ES
    Obstet Gynecol Clin North Am; 1988 Sep; 15(3):545-64. PubMed ID: 2852334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.